YY1 is overexpressed in many forms of carcinomas including HCC, the expression of which was commonly correlated with advanced malignancy or poor clinical outcomes (Tsang et al, 2016; Zhang et al, 2017; Sarvagalla et al, 2019). The gene discussed is YY1; the disease is hepatocellular carcinoma.